BILS

$BILS chatter on StockTwits

• 
  Davy Dave Charts@DavyDaveChartsJun 10

  Watching $BILS accumulation/distribution on the daily, cash positions are increasing. $SPY $QQQ $IWM

  View on StockTwits ↗
• 
  Davy Dave Charts@DavyDaveChartsMay 27

  Both $BIL and $BILS had an uptick in accumulation/distribution… now a sell signal for my experimental TSP swing indicator. Have to work on another confluence because it gave me a buy signal last week.

  View on StockTwits ↗
• 
  Davy Dave Charts@DavyDaveChartsMay 12

  A/D on $BILS dropped today market likely going higher this week. 750 wouldn’t surprise me. $SPY

  View on StockTwits ↗
• 
  Davy Dave Charts@DavyDaveChartsMay 9

  $BILS 3-12 month T-Bills ETF's accumulation/distribution indicator seems to be trying to put a bottom. As cash equivalent positions accumulate, we can see a correlation to selling pressure in the indices. When these positions are distributed, the opposite occurs with the indices, as this signals capital being freed up to enter the markets. $BILS A/D has just made a higher low. Caution for the FOMOe's here... don't be the exit liquidity. $SPY $QQQ $IWM $DIA

  View on StockTwits ↗
• 
  Davy Dave Charts@DavyDaveChartsMay 7

  $BILS $SPX $SPY $VOO this is the signal that I foolishly neglected to put weight on. Sometimes you don’t listen to yourself.

  View on StockTwits ↗
• 
  Davy Dave Charts@DavyDaveChartsMay 7

  $BILS $DIA $IWM $QQQ $SPY hmmm… 🤔 this might be my go to indicator moving forward.

  View on StockTwits ↗
• 
  Davy Dave Charts@DavyDaveChartsMay 6

  Not much BUT first time, since early April, that we're seeing a rise in the accumulation/distribution of $BILS which indicates potential increase in cash positions with 3-12 month T-Bills. How do you build cash? Selling, of course. Exactly what's being sold is hard to pinpoint but it's something to keep an eye on, at these astronomical highs. $SPY $QQQ $DIA $IWM

  View on StockTwits ↗
• 
  Davy Dave Charts@DavyDaveChartsApr 30

  @Kennyt67 the AD is for 3-12 month T-Bills etf $BILS which is a good gauge for cash. its decreasing so cash is being deployed. the tech sector is sucking it up the most.

  View on StockTwits ↗
• 
  Davy Dave Charts@DavyDaveChartsApr 15

  $SPY $QQQ I know the volume has been in focus lately BUT when we look at the accumulation/distribution of $BILS the 3-12 month T-Bills, we can't ignore the big drop. Why? This is dry powder moving from the sidelines and, obviously, into the markets. So, volume hasn't been painting the entire picture. The drop in the AD of $BILS started a few days before the March 30 bottom. This rally could go on a little longer but I'm still very skeptical and not chasing.

  View on StockTwits ↗
• 
  Davy Dave Charts@DavyDaveChartsMar 28

  I'm not saying that we have bottomed. However, here is something to consider, given how overextended to the downside we are, for now. The 3-12 month T-Bill ETF $BILS could, relibly, be a gauge for institutional cash. When $SPX $SPY $VOO was in distribution and dumping, we saw accumulation. The interesting this, however, is that $BILS has a nascent distribution. Where this cash could be going is anyone's guess BUT there is historical precedent to distribution in this ETF signaling potential capital flowing back into equities. For now, if we start to bottom here, it is likely a dead cat bounce. Just something to consider and not any bold prediction on my end.

  View on StockTwits ↗
• 
  Matthew Joseph@BinaryLogicBullishDec 9

  $SCNX [Again] Two (2) FDA approved drugs targeting unique/distinct markets totaling nearly $500M in domestic (US), annualized sales. Arbli was launched mid-August and already showed a $5M annualized run rate prior to scaling across national formularies. Exclusive IP protection thru 2041. Just a 15% penetration rate equates to $40-50M annualized revenue against a market cap of $25M. Separately-Rezenopy is scheduled to launch in Q1-2026 into a domestic market (narcan) measured in $BILS, though specific nasal spray retail approximates $150-200M. Another 15% penetration rate here implies $20-30M annualized revenue, accretive to Arbli. $40-60M revenue, multiple additional drugs under consideration in pipeline, experienced management launching novel pharma products, established production and marketing agreements. More than $8.0M in liquidity (equity placements) against debt that has largely been converted with $2.28 strike (appx). Multiplier upside (IMO) https://finance.yahoo.com/news/updated-lineup-announced-iaccess-alphas-140000061.html

  View on StockTwits ↗
• 
  Matthew Joseph@BinaryLogicDec 16

  $PTHRF $BILS

  View on StockTwits ↗
• 
  Matthew Joseph@BinaryLogicBullishDec 14

  $ICCM So the Company has already shown ProSense cryoblation efficacy in breast tumor elimination, now similar strong results in treating benign/malignant kidney tumors. The Company is securing its technology across multiple (global) markets and verticals (breast, kidney, lung and liver) with a total addressable market measures in $Bils. ICCM has a $60Mils valuation. Watch the $1.4 resistance on the 1YR daily. If/where the SP breaks above that line, this could get very interesting (IMO). [Again] $0.55-0.60 was the place to start/build/add (below). https://finance.yahoo.com/news/icecures-prosense-cryoablation-safe-effective-133000097.html

  View on StockTwits ↗
• 
  Matthew Joseph@BinaryLogicBullishDec 10

  $PTHRF Megrez-1 well has reached TD and production casing in-place, completed on-time and to budget. 1200ft section of HC 'discovery' (important) including light crude, 20% porosity, ongoing evaluation to better qualify the well, long-term testing likely. [Again] This Company and its assets should ultimately be measured in $Bils, currently at $0.3Bils market cap. I advocated for GBP 0.17 [$0.23] in August, re-inforced $0.30 just last week for those who were interested in a strong/speculative O&G investment with short/long term potential. 50-200% upside from this level [$0.30] near/intermediate term (IMO). https://polaris.brighterir.com/public/pantheon_resources/news/rns/story/rnj48kx

  View on StockTwits ↗
• 
  Matthew Joseph@BinaryLogicBullishSep 30

  $JD Some workers in Finance/Strategy at $WMT will unfortunately be looking for new jobs, likely in the very near future. This was a colossal, unfortunate mistake measured in $Bils. The Company $WMT will obviously be fine - but what tremendous mistake, measured literally in days.

  View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.